CULLINAN THERAPEUTICS INC (CGEM) Stock Earnings Estimates
NASDAQ:CGEM • US2300311063
13.65 USD
-0.23 (-1.66%)
At close: Feb 20, 2026
13.51 USD
-0.14 (-1.03%)
After Hours: 2/20/2026, 8:22:34 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 18.94M | 141.16M -100.00% | 22.802M | 24.116M 5.76% | 21.191M -12.13% | 98.441M 364.54% | 231.4M 135.06% | 825.3M 256.66% | N/A | ||||||
| EBITDA YoY % growth | -22.2M -52.58% | -60.28M -171.53% | -67.9M -12.64% | 147.98M -91.53% | -195.671M -46.36% | -198.123M -3.30% | -229.155M -16.55% | -185.976M 18.84% | -163.261M 12.21% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -22.27M -52.64% | -60.34M -170.95% | -67.95M -12.61% | 148.39M -91.52% | -196.334M -46.50% | -197.881M -3.29% | -245.293M -24.57% | -212.739M 13.27% | -229.103M -7.69% | -282.059M -23.11% | -321.147M -13.86% | -339.711M -5.78% | -387.906M -14.19% | -262.242M 32.40% | |
| Operating Margin | N/A | N/A | -358.76% | 105.12% | N/A | N/A | N/A | -932.99% | -950.00% | -1,331.03% | -326.23% | -146.81% | -47.00% | N/A | |
| EPS YoY % growth | N/A | N/A | -1.50 9.41% | 2.38 258.00% | -4.17 -255.70% | -3.12 17.89% | -3.60 -18.87% | -3.18 11.83% | -2.81 11.56% | -3.43 -22.02% | -3.04 11.31% | -2.84 6.71% | 2.85 200.36% | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.82 -11.91% | -0.86 -16.47% | -0.84 21.83% | -0.84 -9.62% | -0.57 29.92% | -0.85 1.78% | -0.86 -2.44% | -0.87 -2.72% | -0.89 -55.01% |
| Revenue Q2Q % growth | 3.4M | 27.863M | N/A | N/A | N/A | N/A | |||
| EBITDA Q2Q % growth | -37.006M 32.40% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -57.445M -4.35% | -56.871M -3.41% | -58.701M 22.56% | -56.237M -1.15% | -28.776M 49.91% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.77 -11.59% | -0.98 | 0.21 | 21.14% |
| Q2 2025 Q2Q % growth | -1.07 -42.67% | -0.85 | -0.22 | -25.93% |
| Q1 2025 Q2Q % growth | -0.74 13.95% | -0.82 | 0.08 | 9.46% |
| Q4 2024 Q2Q % growth | -0.73 -35.19% | -0.77 | 0.04 | 5.54% |
| Q3 2024 Q2Q % growth | -0.69 24.18% | -0.82 | 0.13 | 16.07% |
| Q2 2024 Q2Q % growth | -0.75 8.54% | -0.74 | -0.01 | -1.34% |
| Q1 2024 Q2Q % growth | -0.86 39.44% | -1.01 | 0.15 | 14.81% |
| Q4 2023 Q2Q % growth | -0.54 8.47% | -0.98 | 0.44 | 44.93% |
| Q3 2023 Q2Q % growth | -0.91 -68.52% | -0.94 | 0.03 | 3.20% |
| Q2 2023 Q2Q % growth | -0.82 -121.75% | -0.99 | 0.17 | 17.12% |
| Q1 2023 Q2Q % growth | -1.42 -425.93% | -1.00 | -0.42 | -42.06% |
| Q4 2022 Q2Q % growth | -0.59 20.27% | -0.68 | 0.09 | 13.02% |
| Q3 2022 Q2Q % growth | -0.54 -35.00% | -0.99 | 0.45 | 45.23% |
| Q2 2022 Q2Q % growth | 3.77 1,147.22% | 5.53 | -1.76 | -31.76% |
| Q1 2022 Q2Q % growth | -0.27 | -0.62 | 0.35 | 56.61% |
| Q4 2021 Q2Q % growth | -0.74 74.13% | -0.48 | -0.26 | -53.27% |
| Q3 2021 Q2Q % growth | -0.40 | -0.43 | 0.03 | 7.36% |
| Q2 2021 Q2Q % growth | -0.36 | -0.42 | 0.06 | 14.95% |
| Q1 2021 Q2Q % growth | 0.00 | 0.07 | -0.07 | -100.00% |
| Q4 2020 Q2Q % growth | -2.86 | -0.39 | -2.47 | -628.29% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | 280.5M | -280.5M | -100.00% | |
| Q1 2022 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | 18.94M | 19.38M | -440K | -2.27% |
| Q4 2020 Q2Q % growth | 9.18M | -9.18M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.03% | 4.24% | -0.04% | 6.3% |
| Revenue | N/A | N/A | N/A | N/A |